ivabradine has been researched along with Diabetic Neuropathies in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
LaĆnez, S; McNaughton, PA; Mehta, I; Tsantoulas, C; Vilar, B; Wong, S | 1 |
1 other study(ies) available for ivabradine and Diabetic Neuropathies
Article | Year |
---|---|
Hyperpolarization-activated cyclic nucleotide-gated 2 (HCN2) ion channels drive pain in mouse models of diabetic neuropathy.
Topics: Analgesics; Animals; Benzazepines; Cyclic AMP; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Disease Models, Animal; Gene Deletion; Hyperalgesia; Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels; Ivabradine; Nociception; Pain; Potassium Channels; Proto-Oncogene Proteins c-fos; Sensory Receptor Cells; Skin; Spinal Cord Dorsal Horn; Streptozocin | 2017 |